FDA Approves Nivolumab for Fully Fixed Stage IIB/C Melanoma
by metastatic subcutaneous melanoma Image courtesy of DermNetZ Treatment for patients with melanoma is undergoing a paradigm shift. In October 2023, the FDA approved nivolumab (Opdivo; …
metastatic subcutaneous melanoma Image courtesy of DermNetZ Treatment for patients with melanoma is undergoing a paradigm shift. In October 2023, the FDA approved nivolumab (Opdivo; …